John E. Chapoton - 02 Jan 2025 Form 4 Insider Report for SAUL CENTERS, INC. (BFS)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
02 Jan 2025, 17:11:22 UTC
Prior SEC filing
02 Oct 2024
Next SEC filing
02 Apr 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Carlos L. Heard, by Power of Attorney

Key filing fact

John E. Chapoton filed Form 4 for SAUL CENTERS, INC. (BFS) on 02 Jan 2025.

Key facts

  • This page summarizes John E. Chapoton's Form 4 filing for SAUL CENTERS, INC. (BFS).
  • 1 reported transaction and 10 derivative rows are listed below.
  • Accepted by SEC: 02 Jan 2025, 17:11.

Change

  • Previous filing in this sequence was filed on 02 Oct 2024.
  • Current net transaction value: +$16,250.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BFS holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
9,466
Date
02 Jan 2025
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BFS transaction Derivative

Phantom Stock

Award

Transaction value
$16,250
Shares
+419
Change %
+1.6%
Price
$38.80
Shares after
26,053
Date
02 Jan 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
419
Exercise price
Footnotes
F1, F2, F3
BFS holding Derivative

Director Stock Option

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
2,500
Date
02 Jan 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,500
Exercise price
$51.07
BFS holding Derivative

Director Stock Option

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
2,500
Date
02 Jan 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,500
Exercise price
$57.74
BFS holding Derivative

Director Stock Option

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
2,500
Date
02 Jan 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,500
Exercise price
$59.41
BFS holding Derivative

Director Stock Option

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
2,500
Date
02 Jan 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,500
Exercise price
$49.46
BFS holding Derivative

Director Stock Option

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
2,500
Date
02 Jan 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,500
Exercise price
$55.71
BFS holding Derivative

Director Stock Option

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
2,500
Date
02 Jan 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,500
Exercise price
$50.00
BFS holding Derivative

Director Stock Option

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
2,500
Date
02 Jan 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,500
Exercise price
$43.89
BFS holding Derivative

Director Stock Option

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
2,500
Date
02 Jan 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,500
Exercise price
$47.90
BFS holding Derivative

Director Stock Option

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
2,500
Date
02 Jan 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,500
Exercise price
$33.79
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

New phantom shares are issuable pursuant to the Issuers Deferred Compensation Plan for Directors, as amended and restated effective May 17, 2024 (the Deferred Compensation Plan), under its 2024 Stock Incentive Plan. Phantom shares issued prior to May 17, 2024, continue to be subject to the terms of the Issuers deferred compensation plan for directors in effect prior to the amendment and restatement of the Deferred Compensation Plan.

Footnote F2

The conversion of phantom shares issued on or after May 17, 2024, into shares of the Issuers common stock is governed pursuant to terms of the Issuers Deferred Compensation Plan under its 2024 Stock Plan and the reporting persons Deferred Fee Agreement. The conversion of phantom shares issued prior to May 17, 2024, into shares of the Issuers common stock is governed pursuant to the terms of the Issuers deferred compensation plan for directors in effect prior to the amendment and restatement of the Deferred Compensation Plan and the reporting persons Deferred Fee Agreement.

Footnote F3

Includes 388.019 shares awarded October 31, 2024 as dividend reinvestments on shares of phantom stock held by the reporting person pursuant to the Deferred Compensation Plan.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .